Abstract:We have read with interest the comment of McDermott et al.1 on our article “Short pulse width widens the therapeutic window of subthalamic neurostimulation”.2 While the authors provide an elegant and sophisticated argument trying to prove our data wrong, they disregard a simple rule of experimentation from the viewpoint of theoretical biophysics: Deep brain stimulation systems do not have a “charge knob” to control the output of the neurostimulator. As correctly pointed out by McDermott et al., charge is the product of pulse duration and current. Both variables are controlled independently by the programmer and may be used to improve the selectivity of neurostimulation within a mixed nervous tissue containing target elements of deep brain stimulation (DBS) as well as side-effect elements. Our article describes from a clinical and experimental point of view, how to use the chronaxie relationship in clinical programming in order to avoid typical side effects of neurostimulation such as dysarthria or impaired fine motor skills by inadvertent stimulation of the pyramidal tract. In this experiment, the impact of a single variable (pulse duration) on the outcome variable current was assessed based on a threshold response. Their revised graph was simply showing the theoretical relationship between charge and pulse duration (which is trivial, because charge is the product of current amplitude and pulse duration as pointed out above), but was not experimentally assessed. We have a long experience in teaching novel programmers in adjusting the parameters of neurostimulation, which turns out to be a difficult task for clinicians, and had to perform multiple troubleshooting sessions ourselves in patients with poorly programmed DBS systems. The theoretical sophisticism of McDermott et al. adds confusion rather than providing a much needed practical guideline for DBS programming. We emphasize based on our experimental data and our clinical experience that DBS systems should be programmed treating pulse duration as a “constant” fixed at a low value (30–60 μsec depending on the hardware used) while using current or voltage for “dosing” the therapeutic response irrespective of any theoretical charge-pulse duration relationship.

The Grammar of the Tic in Gilles de La Tourette's Syndrome

Reply to comment on: Short pulse width widens the therapeutic window of subthalamic neurostimulation

Biodegradation of Aflatoxin B1 in Peanut Oil by an Amphipathic Laccase-Inorganic Hybrid Nanoflower

A Bioinspired Single-Atom Fe Nanozyme with Excellent Laccase-Like Activity for Efficient Aflatoxin B1 Removal

Targeted Detoxification of Aflatoxin B1 in Edible Oil by an Enzyme-Metal Nanoreactor

Highly Dispersed Magnetite Nanoparticles on Biochar with Sulfonation Modification for Simultaneous Removal of Arsenite and Tetracycline from Aqueous Solutions: Performance and Mechanistic Insight

Laccase immobilization on core-shell magnetic metal-organic framework microspheres for alkylphenol ethoxylate compound removal

Co-immobilization of Laccase and TEMPO Onto Amino-Functionalized Magnetic Fe3O4 Nanoparticles and Its Application in Acid Fuchsin Decolorization

Outcomes of Implantation of an Artificial Cornea, AlphaCor: Effects of Prior Ocular Herpes Simplex Infection

Immobilization of Laccase by Alkali-Etched Bimetallic CoCu-MOF To Enhance Enzyme Loading and Congo Red Degradation

Amino-functionalized MOF immobilized laccase for enhancing enzyme activity stability and degrading Congo red

Catalyzed degradation of polycyclic aromatic hydrocarbons by recoverable magnetic chitosan immobilized laccase from Trametes versicolor

Thermal imaging bundle - A potential tool to enhance minimally invasive medical procedures

Co-Immobilization of Enzymes and Metals on the Covalent-Organic Framework for the Efficient Removal of Mycotoxins.

Immobilization of laccase on magnetic mesoporous silica as a recoverable biocatalyst for the efficient degradation of benzo[a]pyrene

Degradation of Aflatoxin B1 by recombinant laccase extracellular produced from Escherichia coli

Superparamagnetic MnFe alloy composite derived from cross-bindered of chitosan/rice husk waste/iron aluminate spinel hercynite for rapid catalytic detoxification of aflatoxin B1: Structure, performance and synergistic mechanism

Improved method for ultraviolet irradiation of cultured cells.

Laccase immobilized on chitosan-coated Fe3O4 nanoparticles as reusable biocatalyst for degradation of chlorophenol

Construction of carbon-doped iron-based nanozyme for efficient adsorption and degradation to synergistic removal of aflatoxin B1

A robust biocatalyst based on laccase immobilized superparamagnetic Fe3O4@SiO2–NH2 nanoparticles and its application for degradation of chlorophenols